PT  - JOURNAL ARTICLE
AU  - Akinocho, Herve
AU  - Brackstone, Ken
AU  - Eastment, Nia
AU  - Fantognon, Jean-Paul
AU  - Head, Michael G
TI  - COVID-19 vaccine hesitancy and conspiracy beliefs in Togo: Findings from two cross-sectional surveys
AID  - 10.1101/2023.08.24.23294554
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.08.24.23294554
4099  - http://medrxiv.org/content/early/2023/08/25/2023.08.24.23294554.short
4100  - http://medrxiv.org/content/early/2023/08/25/2023.08.24.23294554.full
AB  - Togo is a low-income country in West Africa. Estimates suggest that only 25% of the Togolese population have received at least one dose of any COVID-19 vaccine by June 2023. Whilst the early phase of the pandemic vaccine rollout across 2021 was dominated by higher-income countries taking much of the available supply, there have long been sufficient supplies for all nations. Thus, there remains a need to understand reasons for low uptake in countries such as Togo. Two cross-sectional telephone surveys of Togo residents were conducted in December 2020 and January 2022. These surveys asked questions around perceptions of COVID-19, trust in public health messaging, belief in conspiracy theories, and hesitancy around COVID-19 vaccination. Analyses here focus on unvaccinated respondents. Across Survey 1 (N = 1430) and Survey 2 (N = 212), 65% of respondents were men, 47% lived in Lomé (capital city of Togo), 25% completed higher education, 67% were married, and 69% were Christian. Between Surveys 1 and 2, overall hesitancy (33.0% to 58.0%) and beliefs in conspiracy theories (29% to 65%) significantly increased. Using logistics regression, governmental mistrust was the strongest significant predictor of hesitancy (OR: 2.90). Participants who indicated agreement or uncertainty with at least one conspiracy belief also predicted greater vaccine hesitancy (OR: 1.36). Proactive approaches to public health messaging, that better understand reasons for hesitancy across different demographics, can support uptake of COVID-19 vaccinations within Togo. This includes health promotion campaigns that use locally and nationally trusted knowledge providers (e.g. the health service or religious leaders) for greatest effectiveness at reducing impact of misinformation. Key future research should focus around knowledge gaps and areas of mistrust created by the pandemic, such as the impact of misinformation upon routine immunisation uptake.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by the Clinical Informatics Research Unit, at the University of Southampton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study received ethical approvals from the Togo Bioethics Research Committee (reference 006/2020/CRBS).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe dataset is openly-available at https://doi.org/10.6084/m9.figshare.23989332.v1 https://doi.org/10.6084/m9.figshare.23989332.v1